Science Explorer Interactive view Map

Dr Falk Pharma (Germany)

Research works
48
▼ 59% vs 2013–17
Citations
1.2k
25.4 per fractional work
Top-10% rate
14.5%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Dr Falk Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.44× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.69× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.65× its world share, 0 worksImmunology and Micro…Chemistry: 0.13× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.09× its world share, 0 worksEngineeringHealth Professions: 0.79× its world share, 0 worksHealth ProfessionsMedicine: 3.99× its world share, 6 worksMedicineNursing: 0.53× its world share, 0 worksNursingPsychology: 0.68× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Who are the top researchers at Dr Falk Pharma (Germany)?

Ranked on the composite score, Roland Greinwald lead among researchers whose main affiliation is Dr Falk Pharma (Germany).

  1. 1 Roland Greinwald Germany · #1,116,791 worldwide 18 citations · 26 works
All ranked researchers at Dr Falk Pharma (Germany)

Which keywords describe research at Dr Falk Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Management, Inflammatory Bowel Disease, Pathogenesis, Treatment, Guidelines and Children.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology13▲ 6.7×24 topics
  2. Diagnosis8▲ 16×12 topics
  3. Management8▲ 21×11 topics
  4. Inflammatory Bowel Disease7▲ 129×4 topics
  5. Pathogenesis6▲ 23×5 topics
  6. Treatment5▲ 8.1×13 topics
  7. Guidelines4▲ 19×4 topics
  8. Children4▲ 33×5 topics
  9. Genetics4▲ 11×4 topics
  10. Adults4▲ 104×2 topics
  11. Immunology4▲ 64×2 topics
  12. Crohn's Disease4▲ 93×2 topics
  13. Eosinophilic Esophagitis4▲ 254×1 topic
  14. Histologic Remission4▲ 254×1 topic
  15. Therapies4▲ 210×1 topic
  16. Ulcerative Colitis4▲ 210×1 topic
  17. Inflammation3▲ 2.9×12 topics
  18. Liver Transplantation3▲ 43×4 topics
  19. Proton Pump Inhibitors3▲ 75×2 topics
  20. Epidemiological Study3▲ 73×2 topics
  21. Insulin Resistance3▲ 12×3 topics
  22. Metabolic Syndrome3▲ 6.6×4 topics
  23. Collagenous Colitis3▲ 208×1 topic
  24. Hepatic Steatosis3▲ 36×2 topics
  25. Microscopic Colitis3▲ 208×1 topic
  26. Hepatocellular Carcinoma2▲ 24×2 topics
  27. NAFLD2▲ 47×1 topic
  28. NASH2▲ 47×1 topic
  29. Immunosuppressive Therapy2▲ 26×3 topics
  30. Chemotherapy2▲ 6.7×10 topics
  31. Autoimmune Hepatitis2▲ 229×1 topic
  32. Primary Biliary Cirrhosis2▲ 229×1 topic
  33. ATP-dependent Transporters2▲ 76×1 topic
  34. Multidrug Resistance2▲ 66×1 topic
  35. Risk Factors2▲ 3.5×5 topics
  36. Intestinal Permeability2▲ 66×2 topics
  37. Prevalence2▲ 8.2×3 topics
  38. Celiac Disease1▲ 149×1 topic
  39. Genetic Variants1▲ 12×2 topics
  40. Glaucoma1▲ 16×3 topics

Which research topics does Dr Falk Pharma (Germany) publish most on?

By volume in 2022–2025: Eosinophilic Esophagitis, Inflammatory Bowel Disease, Receptor Mechanisms and Signaling and Gastric Cancer Management and Outcomes.

  1. 1 Eosinophilic Esophagitis Surgery 2 works
  2. 2 Inflammatory Bowel Disease Genetics 0 works
  3. 3 Receptor Mechanisms and Signaling Molecular Biology 0 works
  4. 4 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  5. 5 Drug Transport and Resistance Mechanisms Oncology 0 works
  6. 6 Esophageal and GI Pathology Surgery 0 works
  7. 7 Colorectal Cancer Treatments and Studies Oncology 0 works
  8. 8 Eosinophilic Disorders and Syndromes Rheumatology 0 works
  9. 9 Gastroesophageal reflux and treatments Gastroenterology 0 works
  10. 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.5%not open50.5%

World: 28% of research is openly available.

with international co-authors46.2%domestic only53.8%

World: 19% is written across borders.

How has Dr Falk Pharma (Germany)'s research output changed?

Output in 2018–2022 was 59% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Freiburg im Breisgau

All research institutions in Freiburg im Breisgau

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.